Prorenin and angiotensin-dependent renal vasoconstriction in type 1 and type 2 diabetes

Journal of the American Society of Nephrology

Volumn 17, Issue 12, 2006, Pages 3293-3299

  Stankovic, Ana R ^a   Fisher, Naomi D L ^a   Hollenberg, Norman K ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOHIPPURIC ACID; ANGIOTENSIN; BIOCHEMICAL MARKER; CAPTOPRIL; GLUCOSE; INSULIN; INULIN; POTASSIUM; PRORENIN; RENIN; SODIUM;

4 AMINOHIPPURIC ACID CLEARANCE; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DRUG EFFECT; FEMALE; HEMODYNAMICS; HORMONE RESPONSE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INULIN CLEARANCE; KIDNEY BLOOD VESSEL; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PLASMA RENIN ACTIVITY; POTASSIUM INTAKE; PRIORITY JOURNAL; RISK FACTOR; SODIUM INTAKE; VASOCONSTRICTION;

EID: 33845254840     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006080859     Document Type: Article

References (24)

1. Lansang MC, Price DA, Laffel LMB, Osei SY, Fisher NDL, Erani D, Hollenberg NK: Renal vascular responses to captopril and to candesartan in patients with type 1 diabetes mellitus. Kidney Int 59: 1432-1438, 2001
2. Luetscher JA, Fredric MD, Kraemer FB, Wilson DM, Schwartz HC, Bryer-Ash M: Increased plasma inactive renin in diabetes mellitus. N Engl J Med 312: 1412-1417, 1985
3. Luetscher JA, Kraemer FB, Wilson DM: Prorenin and vascular complications of diabetes. Am J Hypertens 2: 382-386, 1989
4. Franken AA, Derkx FH, Man in't Veld AJ, Hop WC, van Rens GH, Peperkamp E, de Jong PT, Schalekamp MA: High plasma prorenin in diabetes mellitus and in correlation with some complications. J Clin Endocrinol Metab 71: 1008-1015, 1990
5. Wilson DM, Luetscher JA: Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus. N Engl J Med 323: 1101-1106, 1990
6. Danser AH, van den Dorpel MA, Deinum J, Derkx FH, Franken AA, Peperkamp E, de Jong PT, Schalekamp MA: Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy. J Clin Endocrinol Metab 68: 160-167, 1989
7. Deinum J, Ronn B, Mathiesen E, Derkx FH, Hop WC, Schalekamp MA: Increase in serum prorenin precedes onset of microalbuminuria in patients with insulin-dependent diabetes mellitus. Diabetetoloia 42: 1006-1010, 1999
8. Nguyen G, Burckle CA, Sraer J-D: Renin/prorenin-receptor biochemistry and functional significance. Curr Hypertens Rep 6: 129-132, 2004
9. Chai W, Jan Danser AHJ: Is angiotensin II made inside or outside of the cell? Curr Hypertens Rep 7: 124-127, 2005
10. Nguyen G, Delarue F, Burckle C, Bouzhir L, Giller T, Sraer JD: Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 109: 1417-1427, 2002
11. Van den Eijnden MM, Saris JJ, de Bruin RJ, de Wit E, Sluiter W, Reudelhuber TL, Schalekamp MA, Derkx FH, Danser AH: Prorenin accumulation and activation in human endothelial cells. Importance of mannose 6-phosphate receptors. Arterioscler Thromb Vasc Biol 21: 911-916, 2001
12. Saris JJ, Derkx FH, Lamers JM, Saxena PR, Schalekamp MA, Danser AH: Cardiomyocytes bind and activate native human prorenin: Role of soluble mannose 6-phosphate receptors. Hypertension 37: 710-715, 2001
13. Veniant M, Menard J, Bruneval P, Morley S, Gonzales MF, Mullins J: Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver. J Clin Invest 98: 1966-1970, 1996
14. Prescott G, Silversides DW, Reudelhuber TL: Tissue activity of circulating prorenin. Am J Hypertens 15: 280-285, 2002
15. Ichihara A, Hayashi M, Kaneshiro Y, Suzuki F, Nakagawa T, Tada Y, Koura Y, Nishiyama A, Okada H, Uddin MN, Nabi N, Ishida Y, Inagami T, Saruta T: Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin. J Clin Invest 114: 1128-1135, 2004
16. National Institute of Diabetes and Digestive and Kidney Diseases: Diabetes Diagnosis. Available at: http://diabetes.niddk.nih.gov/dm/pubs/ diagnosis/index.htm. Accessed July 2006.
17. Fisher NDL, Hollenberg NK: Renin inhibition: What are the therapeutic opportunities? J Am Soc Nephrol 16: 592-599, 2005
18. Hurwitz S, Porter B, Weiss RJ, Jeunemaitre X, Hopkins PN, Hunt SC, Litchfield WR, Williams GH: Influence of sodium intake on the reliability of active renin as a measure of the renin-angiotensin system in essential hypertension. Am J Clin Pathol 115: 304-312, 2001
19. Lansang MC, Stevanovic R, Price DA, Laffel LMB, Hollenberg NK: ACE and non-ACE pathways in the renal vascular response to RAS interruption in type 1 diabetes mellitus. Kidney Int 67: 1033-1037, 2005
20. Skinner SL: Pathophysiology of prorenin. In: The Renin Angiotensin System, Vol. 1, Biochemistry Physiology, edited by Robertson JI, Nicholls MG, New York, Gower Medical Publishing, 1993, pp 1-51
21. Abe J-I, Itoh S, Lerner-Marmarosh N, Ding B, Wang N, Maekawa N: Functional role of p90 ribosomal S6 kinase (p90RSK)-mediated prorenin converting enzyme (PRECE) induction: Implication in diabetic (DM) myocardium [Abstract]. Circulation 112[Suppl II]: 274, 2005
22. Lenz T, Sealey JE, Maack T, James GD, Heinrikson RI, Marion D, Laragh JH: Half-life, hemodynamic, renal and hormonal effects of prorenin in cynomolgus monkeys. Am J Physiol 260: 804-810, 1991
23. Ahmed SB, Hovind P, Parving H-H, Rossing P, Price DA, Laffel LM, Lansang MC, Stevanovic R, Fisher NDL, Hollenberg NK: Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathy. Diabetes Care 28: 1988-1994, 2005
24. Price DA, Porter LE, Gordon M, Fisher ND, De'Oliveira JM, Laffel LM, Passan DR, Williams GH, Hollenberg NK: The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol 10: 2382-2391, 1999